These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6304571)

  • 21. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature].
    Dall'Aglio V; Rellini G; Charmet P; Cassin M; Variola A; Menin A; Manfroni A; Meneguzzo N; Bazzi A
    G Ital Cardiol; 1983 Sep; 13(9):153-9. PubMed ID: 6363191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in vasodilator therapy for heart failure.
    Cohn JN
    N Engl J Med; 1980 Jun; 302(25):1414-6. PubMed ID: 6246428
    [No Abstract]   [Full Text] [Related]  

  • 24. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 25. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
    Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of hypertensive crisis with captopril].
    Biollaz J; Waeber B; Turini GA; Schaller MD; Brunner HR
    Schweiz Med Wochenschr; 1983 Dec; 113(52):2006-7. PubMed ID: 6364338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of chronic congestive heart-failure by oral captopril.
    Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
    Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of severe chronic cardiac congestive insufficiency with captopril. Short and long-term clinical, hemodynamic and biological effects].
    Lavigne G; Morand P
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):339-48. PubMed ID: 6807251
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin converting enzyme inhibition in heart failure.
    Cleland JG; Dargie HJ; Robertson JI
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):157S-160S. PubMed ID: 6099732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical use of an orally acting converting enzyme inhibitor: captopril.
    Brunner HR; Gavras H; Waeber B; Textor SC; Turini GA; Wauters JP
    Hypertension; 1980; 2(4):558-66. PubMed ID: 6995296
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
    Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 38. [A clinical study on treatment of refractory heart failure with oral captopril].
    Wang ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhibitors of angiotensin convertase (inhibitory ACE) in chronic heart failure].
    Kozák P; Salava T; Hes I; Spacek A; Stárek A
    Vnitr Lek; 1987 Feb; 33(2):123-8. PubMed ID: 3029992
    [No Abstract]   [Full Text] [Related]  

  • 40. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL; Hall D; Rudolph W
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.